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ABSTRACT 
Community pharmacists are readily accessible to patients for counselling services on their disease state, medications and medical 
devices. Previous studies have reported asthma patients’ poor inhaler techniques. This study evaluated community pharmacists’ 
competence for educating asthmatic patients on the use of asthma devices. The cross-sectional study was conducted with 
community pharmacists in Enugu State, Nigeria (May 2017 – July 2017). A 29-item structured self-administered questionnaire 
assessing information on stock, action plan for pharmacists, interventions with asthma patients and factors influencing these 
interventions was utilized. Validated checklists assessed inhaler techniques and peak flow meter use, from participants’ 
demonstrations. Dummy inhalers and peak flow meters were used to teach correct techniques. Of the 116 registered community 
pharmacists, 62 completed and returned their questionnaires (53.4% participation rate). More than half of the participants were 
less than 40 years old (63%), male (71.0%), had community pharmacy experience less than 10 years (67.7%). Few of the 
community pharmacists (3.2%) stocked spacers or peak flow meters. More than half (71%) of the participants claimed to educate 
patients on correct inhaler techniques but a quarter (24.2%) agreed that they lacked competence to educate on inhaler techniques. 
Less than half of them (46.8%) were willing to intervene with asthma patients. Summarily, the demonstrated good techniques 
were: pMDI (35.5%), Accuhaler (29.0%), Turbuhaler (14.5%), pMDI plus spacer (9.7%), peak flow meter (4.8%). The 
community pharmacists demonstrated poor inhaler techniques and were deficient in the knowledge of peak flow meter use which 
limited their roles in asthma management. 
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INTRODUCTION 
 
Asthma is a public health problem that is burdensome to 
patients and their caregivers (Bahadori et al., 2009; GINA, 
2018). It impacts negatively on the quality of life and increases 
the costs of health care (Masoli et al., 2004; Melani et al., 
2011, AL-Jahdali et al., 2013). Asthma affects around 339 
million people globally (Global Asthma Report, 2018). In 
Nigeria, the management of asthma is hindered by poor 
standard of living (Global Asthma Report, 2018). 
Most asthma drugs are administered by inhalation. There are 
checklists to assess proper inhaler techniques for respiratory 
diseases and the steps are ordered (Al-Wasil & Al-
Mohaimeed, 2003; Hassan, 2009; Batterink et al., 2012; 
Bryant et al., 2013). If some of the key steps are missed or 
incorrectly executed, it could lead to insignificant or none of 
the inhaled drug getting to the airways and lungs with possible 
poorly controlled asthma (Masoli et al., 2004; Melani et al., 
2011, AL-Jahdali et al., 2013). Asthma patients have 
demonstrated poor inhaler techniques (Masoli et al., 2004; 
Souza et al., 2009; Batterink et al., 2012; Bryant et al., 2013; 
Price, 2014).  
 Poor asthma control has been caused by inefficient 
communication between the healthcare providers and asthma 
patients, lack of  self- monitoring equipment (such as the peak 
flow meter), and educational materials (Greene et al., 1996).  
Community pharmacists can provide ongoing support and 
management services to asthma patients. They are 
conveniently located in the community to attend to patients, 
with many opening for long hours without the need for 
appointments before consultations (Fathima et al., 2013). 
Health care professionals can educate patients about asthma 
and develop their self-management (Abdelhamid et al., 2008). 
Community pharmacists can help patients self-manage their 
asthma with the proper use of inhalers and the peak flow meter 
to ensure they have well-controlled asthma (NIH, 1995). The 
peak flow meter helps to measure day-to-day variation in 
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breathing which could show the effectiveness of the asthma 
medication and management plan (Adeniyi & Erhabor, 2011). 
Community pharmacists can refer patients with poorly 
controlled asthma to physicians or specialists for medical care. 
Patients from the hospital may fill their prescriptions in the 
hospital pharmacy or in their community pharmacy. 
Pharmacists cannot exempt themselves from the management 
of asthma, as they are custodians of drugs and can put patients 
through their management plan (Abdelhamid et al., 2008). 
They should view themselves as the last line of defense. For 
instance, if medical doctors are busy in the clinic to 
demonstrate proper inhaler techniques or how to use the peak 
flow meter device to asthma patients, the onus rests on the 
shoulders of the pharmacists to do adequate demonstrations at 
the point of dispensing. Research has revealed that some 
hospital pharmacists exempt themselves in the management of 
asthma because they feel the role of asthma management is 
solely the duty of medical doctors (Fink & Rubin, 2005). 
 Pharmaceutical care services can have significant impact 
in reducing health care costs (Abdelhamid et al., 2008). 
Continuous support is required in assisting asthma patients 
with self-management (Lemay et al., 2015). Community 
pharmacists are easily accessible to render these services. 
However, community pharmacists have also demonstrated 
poor handling of asthma devices (Osman et al., 2012). Most 
of these studies employed the mystery patient technique but 
did not go a step further in educating the pharmacists on the 
proper assessed community pharmacists’ roles in promoting 
asthma self-management. Hence, this study was conducted not 
only to evaluate community pharmacists’ competence for 
educating asthmatic patients on the use of asthma devices but 
also to educate these pharmacists on the use of these devices. 
 
MATERIALS AND METHODS 
 
Study Design and Sample population:  
This was a cross-sectional study conducted among community 
pharmacists in Enugu State, South-East, Nigeria, over a period 
of three months (May 2017 – July 2017). Most of the 
community pharmacies in Enugu State are located in the 
capital. The eligibility criteria included community 
pharmacists who worked in Enugu State and gave their 
consent to participate. There were 116 registered community 
pharmacists in Enugu State when this study was conducted, as 
verified from the Pharmacist Council of Nigeria (PCN) Office, 
Enugu State. 
 
Data Collection:  
The 29-item questionnaire was structured and self-
administered. It comprised: demographic information, 
information on stock, action plan for pharmacists, 
interventions with asthma patients and factors influencing 
these interventions. The questionnaire was adapted and 
modified from a previous report by the National Institutes of 
Health (NIH) and questionnaire on asthma management for 
community pharmacists developed by Buckley and Ryder 
(NIH, 1995; Buckley & Ryder, 2012). The checklist by Bryant 
and colleagues (2013) was used to assess the inhaler 
techniques demonstrated by the pharmacists. The checklist by 
Sleath et al. (2011) was used to assess the demonstration of 
peak flow meter use. The researcher introduced himself to the 
community pharmacists who participated in the study and 
explained the objectives of the survey. Informed consent for 
participation was obtained before the questionnaires were 
administered. The community pharmacists were met 
individually. They filled the questionnaires in their 
pharmacies, without the consultation of any reference 
material. Confidentiality was maintained, as the names of the 
participants were not requested for. The filled questionnaires 
were retrieved before the participants were handed dummy 
inhalers and a peak flow meter for demonstration of use. The 
checklists were ticked, as appropriate, immediately after the 
demonstrations by the participants. The participating 
community pharmacists were educated by the researcher who 
demonstrated the correct techniques for the inhaler and peak 
flow meter devices. The community pharmacists were asked 
to make re-demonstrations to the researcher. It was ensured 
that all the steps were correctly demonstrated by the 
community pharmacists, before departure.  
 
Ethical consideration: This study was conducted after 
obtaining ethical approval from the Health Research and 
Ethics Board of the University of Nigeria Teaching Hospital 
(UNTH), Ituku-Ozalla, Enugu State on 23 May, 2017 
(NHREC/05/01/2008B – FWA00002458 – IRB00002323). 
The study was conducted based on the approved protocol. 
 
Data Analysis:  
The IBM SPSS Version 21.0 (IBM Corp, Version 21.0, 
Armonk, NY, USA) was used for the data entry and analysis. 
Descriptive statistics summarized data.  
For Table 5, Strongly Agree (SA) was coded as 5; Agree (A) 
was coded as 4; Neutral (N) was coded as 3; Strongly disagree 
(SD) was coded as 2; Disagree (D) was coded as 1. The code 
responses were reversed in a positive direction for items 1, 4, 
5, 6 and 7 such that higher mean scores indicated positive 





A total of sixty two-questionnaires were completed and 
returned, representing a participation rate of 54.3% (62/116). 
About 63% of the community pharmacists were less than 40 
years old. Most of them (90.3%) had less than 10 years post-
qualification experience (Table 1). Peak flow meters and 
spacers were stocked in few community pharmacies, Figure 1. 
 More than 90% of the community pharmacists claimed to 
educate patients about their asthma medications. However, 
less than 2% of them helped asthma patients use peak flow 
meters appropriately, Figure 2. Less than 5% of the 
community pharmacists claimed to always demonstrate peak 
flow meter use to asthma patients, Table 2. 
 More than half of the community pharmacists did not 
demonstrate exhalation to residual volume in preparation for 
the inhalation of the drug from a pressurized metered dose 
inhaler (pMDI) (67.7%) or Accuhaler devices (75%). Only 
about 13% of them rotated the grip of the Turbuhaler device 
as required. The community pharmacists poorly demonstrated 
all the eight steps for correct pMDI plus spacer use and 
exhibited deficient knowledge of correct peak flow meter use, 
Table 3. 
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Table 1:  
Demographic details of the community pharmacists, n = 62 
Variables n (%) 
Age (in years) 20 -29 13 (21.0) 
30 -39 26 (41.9) 
40 – 49 17 (27.4) 
50 -59 5 (8.1) 
> 60 1 (1.6) 
Gender Male 44 (71.0) 
Female 18 (29.0) 
Post-qualification 
experience (in years) 
< 5 27 (43.5) 
5 -10 29 (46.8) 
11 – 20 6 (9.7) 
> 20 0 (0.0) 
Community pharmacy 
experience (in years) 
< 5 19 (30.6) 
5 -10 23 (37.1) 
11 – 20 17 (27.4) 
> 20 3 (4.8) 
Highest qualification MPharm 6 (9.7) 
MPH 1 (1.6) 
FPCPharm 1 (1.6) 
PhD 0 (0.0) 
None 54 (87.1) 
MPharm = Master of Pharmacy; MPH = Master of Public Health; 
FPCPharm = Fellow of the West African Postgraduate College of 





Figure 1:  
Information on stock, n = 62 
 
 
Overall, the community pharmacists demonstrated poor 
device techniques for all the inhaler devices and the peak flow 
meter, Table 4. 
 Only about 24% of the community pharmacists reported 
that they lack competence to educate asthma patients on 
inhaler techniques. About 60% of the participants reported 
that they lacked competence to educate asthma patients on 
peak flow meter use, Table 5. About half of the community 
pharmacists (46.8%) were willing to intervene with asthma 
patients. 
 
Figure 2:  
Action plan for pharmacists, n = 62 
 
 
Table 2:  
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DISCUSSION 
 
From the results obtained, about half of the participating 
community pharmacists were between 30 – 39 years old while 
over half were males. About a tenth of the participants had 
additional qualification after their Bachelor of Pharmacy 
(B.Pharm) degree. Peak flow meters and spacer devices were 
rarely stocked in the community pharmacies.  Most of the 
participating community pharmacists claimed to educate 
patients about their asthma medications but few actually 
helped these patients use peak flow meters appropriately. Less 
than half of them were willing to intervene with asthma 
patients. Overall, the community pharmacists demonstrated 
poor techniques for all the inhaler devices and the peak flow 
meter. 
Community Pharmacists’ Competence for Educating Asthmatic Patients 
224 Afr. J. Biomed. Res. Vol. 23, No.2 (May) 2020 .   Amorha  et al 
 
Table 3:  
Community pharmacists’ demonstration of asthma devices assessed 
against the eight steps for correct use in the checklists, n = 62 
 
Steps for asthma devices Yes (%) 
pMDI  
1. Remove the cap from the inhaler 59 (95.2) 
2.* Shake the inhaler 33 (53.2) 
3. Hold inhaler upright 33 (53.2) 
4. Exhale to residual volume 20 (32.3) 
5. Place mouthpiece between lips and teeth to seal 
the mouthpiece 
52 (83.9) 
6.* Inhale slowly and simultaneously and activate 
the canister 
31 (50.0) 
7.* Continue slow and deep inhalation 23 (37.1) 




1. * Hold Accuhaler horizontally 36 (58.1) 
2.* Push the lever away from the mouthpiece until 
you hear the ‘click’ 
32 (51.6) 
3. Exhale as much as you can 15 (24.2) 
4. Exhale away from the mouthpiece 15 (24.2) 
5. Place mouthpiece between lips and teeth to seal 
the mouthpiece 
42 (67.7) 
6.* Inhale forcefully and deeply 28 (45.2) 
7. Remove Accuhaler from the mouth 27 (43.5) 
8. Hold breath for 5-10 seconds 20 (32.3) 
Turbuhaler  
1. Remove the cap from inhaler 49 (79.0) 
2.* Keep inhaler upright 27 (43.5) 
3.* Rotate grip anti-clockwise then back until a click 
is heard 
8 (12.9) 
4. Exhale to residual volume 12 (19.4) 
5. Exhale away from mouthpiece 14 (22.6) 
6. Place mouthpiece between teeth and lips 42 (67.7) 
7. * Inhale forcefully and deeply 28 (45.2) 
8. Hold breath for 5-10 seconds 16 (25.8) 
pMDI + Spacer  
1. * Shake the inhaler well 25 (40.3) 
2. Fit the inhaler into the opening at the end of the 
spacer 
9 (14.5) 
3. Place mouthpiece between lips and teeth to seal 
mouthpiece 
10 (16.1) 
4. Breathe out gently 7 (11.3) 
5.* Press the inhaler once only 6 (9.7) 
6. Take 5 – 10 slow breaths in and out through the 
mouth 
6 (9.7) 
7. * Do not remove the spacer from the mouth 
between breaths 
7 (11.3) 
8. Remove spacer from the mouth 6 (9.7) 
Peak Flow Meter  
1. * Set marker to zero 4 (6.5) 
2. Hold meter upright 4 (6.5) 
3. Do not block marker movement 3 (4.8) 
4. * Take a deep breath with mouth open 3 (4.8) 
5. Place meter in mouth and close lips tightly around 
meter 
4 (6.5) 
6. * Exhale hard and fast into meter 3 (4.8) 
7. Check the result 3 (4.8) 
8. Repeat the step 1 – 7 two more times 1 (1.6) 




Table 4:  
Device technique scores for different inhaler devices and peak flow 
meter, n = 62 
Type of 
inhaler/device 




1. pMDI 22 (35.5) 40 (64.5) 
2. Accuhaler 18 (29.0) 44 (71.0) 
3. Turbuhaler 9 (14.5) 53 (85.5) 
4. pMDI plus Spacer 6 (9.7) 56 (90.3) 
5. Peak flow meter 3 (4.8) 59 (95.2) 
* Good technique was defined as having at least five out of eight steps correct, 
including all three essential steps on the checklist for inhaler techniques and 
peak flow meter (Sleath et al., 2011; Bryant et al., 2013). 
* Poor technique was defined as not reaching the standard defined as good 
technique. 
pMDI = pressurized metered dose inhaler 
 
Table 5:  















What factors influence your interventions with asthma patients? 
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SA – Strongly Agree (coded as 5); A – Agree (coded as 4); N – Neutral (coded 
as 3); SD – Strongly disagree (coded as 2); D – Disagree (coded as 1); SDv 
– Standard Deviation 
* The code responses were reversed in a positive direction such that higher 
mean scores indicated positive responses i.e. are highly willing to intervene 
with asthma patients 
 
This study had some strengths and limitations. Some 
pharmacists were not on duty during data collection, despite 
several visits by the researcher. This reduced the sample size. 
Although, the Pharmacists Council of Nigeria stipulates that 
registered community pharmacists should always be available 
to attend to patients whenever their premises are open, this is 
not followed to the letter (PCN, 1992). This is worrisome since 
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community pharmacists are considered the most accessible 
healthcare professionals (Osman et al., 2012).  In addition, this 
study was cross-sectional by design and conducted in a 
Nigerian state. The results obtained might not be generalized 
to other study settings. Some pharmacists declined from 
participation due to their perceived lack of adequate 
knowledge to demonstrate the proper inhaler techniques or 
peak flow meter use. The previous studies that assessed 
pharmacists’ inhaler technique demonstrations employed the 
mystery patient technique. They did not go steps further in 
educating the pharmacists on the proper inhaler techniques. 
Although with the mystery patient technique, the pharmacist 
is less likely going to be self-conscious and produce results 
closer to reality, it was not necessary in this study. The 
researcher introduced himself as a pharmacist who was 
enthusiastic about improving inhaler techniques of 
pharmacists and patients; stated what poor inhaler techniques 
could cause and included that he would teach the proper 
inhaler techniques after their demonstrations. Demonstrating 
proper inhaler techniques to all the community pharmacists 
who participated is a highlight of this research. 
 Few of the community pharmacists stocked peak flow 
meters and spacer devices in their pharmacies. This is similar 
to a study in Alberta, Canada, where most of the community 
pharmacies had no peak flow meter in stock (Banh et al., 
2016). Few prescriptions for peak flow meters or spacer 
devices could be a reason for the low stock and might 
contribute to the poor knowledge of the use of these devices 
(Onyedum et al., 2013). This is further buttressed by the 
findings of this study that less than a tenth of the community 
pharmacists regularly demonstrate peak flow meter use to 
asthma patients. Few of the participants also reported advising 
asthmatic patients on the importance of regular peak 
expiratory flow rate checks. A large proportion of the 
community pharmacists reported lack of competence to 
educate asthmatic patients on peak flow meter use.   
 Furthermore, a large fraction of the community 
pharmacists claimed to educate patients about their asthma 
medications. In asthma management, patient education is 
vital. In a Serbian study, pharmacists positively influenced 
health outcomes by educating asthma patients (Kovacevic et 
al., 2017. Only about a quarter of the participants claimed to 
help asthma patients understand their asthma management 
plan. Although physicians in Nigeria might not frequently use 
a written action plan for asthma patients, it may present an 
opportunity for pharmacists to collaborate with physicians in 
this regard (Banh et al., 2016). 
 Many factors could be responsible for poor knowledge of 
proper inhaler techniques by patients. These include 
pharmacists’ deficient knowledge of asthma management and 
patients’ unawareness that pharmacists can assist (Osman et 
al., 2012). In addition, social barriers may impede the use of 
inhalers (Alrasbi & Sheikh, 2008). Health professionals, 
especially community pharmacists who are readily accessible 
to patients should do well in educating asthma patients on 
proper inhaler techniques (Kumar et al., 2009). 
Few community pharmacists were willing to intervene with 
asthma patients. Pharmacists’ involvement in asthma 
management may improve outcomes. In a study conducted by 
Kovacevic et al. (2017), community pharmacists’ 
interventions improved adherence and asthma control, 
minimizing costs and need for referrals. In this study, only 
about a quarter of the community pharmacists, often or always 
provide verbal information on new drugs with less than a 
quarter checking inhalation technique every 6 - 12 months or 
advising to ask doctors on action plan. Pharmacy interventions 
have been impactful (Alrasbi & Sheikh, 2008). 
Overall, the community pharmacists demonstrated poor 
techniques for all the inhaler devices and the peak flow meter. 
They fared worse with the peak flow meter and pMDI plus 
spacer. Other studies have also reported more than half of the 
participants having poor inhaler technique (Thompson et al., 
1994; Alotaibi et al., 2016; Garcia-Cardenas et al., 2016).  In 
a study conducted in Sudan, many pharmacists missed the 
steps for correct inhaler techniques (Osman et al., 2012). 
Another study conducted in Anambra State, Nigeria indicated 
that community pharmacists were not versed in the use of the 
metered dose inhaler (Nduka et al., 2016). 
 The most common error by participants in our study, for 
all devices, was failure to demonstrate exhalation to residual 
volume, away from the mouthpiece (for the dry powder 
inhalers) (Hassan, 2009; Melani et al., 2011; Bryant et al., 
2013). If there is no exhalation to residual volume in 
preparation for the inhalation of the drug, it may lead to poor 
inspiratory rate and reduce the medication that gets to the 
lungs. The rescue inhalers usually come as pMDIs. Using 
inhalers appropriately may be life-saving. 
 In another Nigerian study, the scores of the respondents 
were not influenced by certifications or number of years in 
practice. The engagement of health care providers in frequent 
training and updates on asthma management can improve their 
skills and by extension, that of their patients. The routine 
training and retraining of health care providers through 
continued professional development could improve the 
inhaler skills of both the health care providers and the patients 
(Nduka et al., 2016). Pharmacists need to continually update 
themselves. In our study, the community pharmacists were 
most unfamiliar with the peak flow meter and spacer devices. 
In another study, pharmacists were majorly unfamiliar with 
the use of spacers and the dry powder inhalers (Alrasbi & 
Sheikh, 2008). 
 There is dire need for pharmacists to understand that they 
are relevant in asthma management. Community pharmacists 
should be well-grounded in educating asthma patients on the 
optimum use of inhalers, spacers and peak flow meters. 
Pharmaceutical companies that manufacture or market asthma 
devices should be encouraged to provide dummies for 
community pharmacists, as it would aid demonstrations to 
asthmatic patients or their caregivers. More studies should be 
conducted that do not only reveal deficiencies in the 
knowledge of inhaler techniques among health professionals 
but also educate these health professionals on the proper 
techniques. Monitoring of symptoms and peak expiratory flow 
rate are important for self-management. Lung function could 
be objectively measured with the peak flow meter. Physicians 
who attend to asthmatic patients should encourage these 
patients to utilize peak flow meters. This would also 
encourage community pharmacists to stock peak flow meters 
for the benefit of the patients. 
Community Pharmacists’ Competence for Educating Asthmatic Patients 
226 Afr. J. Biomed. Res. Vol. 23, No.2 (May) 2020 .   Amorha  et al 
Continuous educational programmes for community 
pharmacists regarding the proper use of asthma-related 
devices such as inhalers, spacers, peak flow meters and 
nebulizers should be initiated. 
 This study concludes that community pharmacists 
demonstrated poor inhaler techniques and were deficient in the 
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